AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33231551 — intervention group
Group type: EXPERIMENTAL
Intervention: Steps2Health intervention with multimedia messaging service messages triggered by step counts
Number of subjects: 78
Study 33231551 — intervention group
Group type: EXPERIMENTAL
Intervention: Steps2Health intervention
Number of subjects: 78
Study 33231551 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 78
Study 34898310 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag-mask ventilation
Number of subjects: 138
Study 34898310 — intervention group
Group type: COMPARATOR
Intervention: Apneic oxygenation
Number of subjects: 138
Study 34254406 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 80
Study 34254406 — intervention group
Group type: COMPARATOR
Intervention: Brisk walking
Number of subjects: 80
Study 36380286 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural analgesia (CSEA)
Number of subjects: 400
Study 36380286 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia (EA)
Number of subjects: 400
Study 32084218 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine administration
Number of subjects: 0
Study 34423649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor pooled (60 or 90 mg BID)
Number of subjects: 21162
Study 34423649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21162
Study 36403804 — intervention group
Group type: EXPERIMENTAL
Intervention: High status threat only
Number of subjects: 139
Study 36403804 — intervention group
Group type: EXPERIMENTAL
Intervention: High acceptance threat only
Number of subjects: 139
Study 36403804 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined threat
Number of subjects: 139
Study 36403804 — intervention group
Group type: COMPARATOR
Intervention: Low evaluative threat
Number of subjects: 139
Study 34656188 — intervention group
Group type: EXPERIMENTAL
Intervention: ebook + PCIT
Number of subjects: 178
Study 34656188 — intervention group
Group type: COMPARATOR
Intervention: traditional PCIT
Number of subjects: 178
Study 33579050 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized diet plan (Intervention Group)
Number of subjects: 34
Study 33579050 — intervention group
Group type: COMPARATOR
Intervention: Nutritional advice on healthy eating practices (Control Group)
Number of subjects: 34
Study 32901611 — intervention group
Group type: EXPERIMENTAL
Intervention: Thulium laser transurethral vaporesection of the prostate (ThuVARP)
Number of subjects: 410
Study 32901611 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 410
Study 34090780 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant callers with Medicaid
Number of subjects: 28651
Study 34090780 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pregnant callers with Medicaid
Number of subjects: 28651
Study 34090780 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant callers
Number of subjects: 28651
Study 34090780 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pregnant callers
Number of subjects: 28651
Study 34090780 — intervention group
Group type: EXPERIMENTAL
Intervention: All callers
Number of subjects: 28651
Study 35709198 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual fishbowl teaching method
Number of subjects: 144
Study 35709198 — intervention group
Group type: COMPARATOR
Intervention: Virtual seminar teaching method
Number of subjects: 144
Study 34241780 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Number of subjects: 0
Study 34241780 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 32187817 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting bioresorbable scaffold (BRS) implantation
Number of subjects: 176
Study 32334527 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional training for 12 weeks
Number of subjects: 0
Study 32334527 — intervention group
Group type: COMPARATOR
Intervention: Strength training for 12 weeks
Number of subjects: 0
Study 32334527 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional training
Number of subjects: 0
Study 32334527 — intervention group
Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 0
Study 32085920 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonetically studied vocal tasks recorded and analyzed by evaluators
Number of subjects: 33
Study 32021219 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Construct Therapy (PCT)
Number of subjects: 0
Study 32021219 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 36058457 — intervention group
Group type: COMPARATOR
Intervention: Zilver (stenting without fasciotomy)
Number of subjects: 60
Study 36058457 — intervention group
Group type: EXPERIMENTAL
Intervention: ZilverFas (stenting with fasciotomy)
Number of subjects: 60
Study 33595420 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinylcholine
Number of subjects: 1230
Study 33595420 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium
Number of subjects: 1230
Study 33595420 — intervention group
Group type: EXPERIMENTAL
Intervention: First attempt intubation failure
Number of subjects: 1230
Study 33595420 — intervention group
Group type: COMPARATOR
Intervention: Successful first attempt intubation
Number of subjects: 1230
Study 33595420 — intervention group
Group type: EXPERIMENTAL
Intervention: History of ear, nose and throat neoplasia
Number of subjects: 1230
Study 32716330 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of feeding tube
Number of subjects: 6
Study 32716330 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of anemia
Number of subjects: 6
Study 32716330 — intervention group
Group type: EXPERIMENTAL
Intervention: Old age
Number of subjects: 6
Study 32716330 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interruption)
Number of subjects: 6
Study 35105560 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal n‐3 long‐chain polyunsaturated fatty acids (n‐3 LCPUFA) supplementation
Number of subjects: 700
Study 35105560 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐dose vitamin D supplementation
Number of subjects: 700
Study 35105560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 700
Study 35105560 — intervention group
Group type: EXPERIMENTAL
Intervention: Early life exposures (infections, low grade inflammation, gut microbiome)
Number of subjects: 700
Study 32747190 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent treatment with pemetrexed plus cisplatin along with EGFR-TKI
Number of subjects: 99
Study 32747190 — intervention group
Group type: COMPARATOR
Intervention: Sequential treatment with EGFR-TKI followed by chemotherapy after progression
Number of subjects: 99
Study 32490650 — intervention group
Group type: EXPERIMENTAL
Intervention: VAH + CAP + SSLF (Group 2)
Number of subjects: 150
Study 32490650 — intervention group
Group type: COMPARATOR
Intervention: VAH + CAP (Group 1)
Number of subjects: 150
Study 36104806 — intervention group
Group type: EXPERIMENTAL
Intervention: MPFLr combined with TTT
Number of subjects: 99
Study 36104806 — intervention group
Group type: COMPARATOR
Intervention: Isolated MPFLr (iMPFLr)
Number of subjects: 99
Study 33020134 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (HypoEx) with blood glucose (BG)≤3.9 mmol/L
Number of subjects: 13
Study 33020134 — intervention group
Group type: COMPARATOR
Intervention: Euglycemia (EuEx) with BG≥4.0, BG≤10.0 mmol/L
Number of subjects: 13
Study 33020134 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (HypoEx)
Number of subjects: 13
Study 35726118 — intervention group
Group type: EXPERIMENTAL
Intervention: External-focus instruction during dual-task walking
Number of subjects: 62
Study 35726118 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal-focus instruction during dual-task walking
Number of subjects: 62
Study 35726118 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal-focus training for 6 weeks
Number of subjects: 62
Study 35726118 — intervention group
Group type: EXPERIMENTAL
Intervention: External-focus training for 6 weeks
Number of subjects: 62
Study 32344105 — intervention group
Group type: EXPERIMENTAL
Intervention: noisy galvanic vestibular stimulation (nGVS)
Number of subjects: 26
Study 32344105 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation (control)
Number of subjects: 26
Study 34990385 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 3266
Study 34990385 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 3266
Study 34606988 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth counseling duration (4 weeks vs. 8 weeks)
Number of subjects: 0
Study 34606988 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy duration (2 weeks vs. 8 weeks)
Number of subjects: 0
Study 34606988 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic screening and referral for social determinants of health via 'AuntBertha' (referral)
Number of subjects: 0
Study 34606988 — intervention group
Group type: COMPARATOR
Intervention: No referral for social determinants of health
Number of subjects: 0
Study 33321698 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional gated recurrent unit model
Number of subjects: 10
Study 33321698 — intervention group
Group type: COMPARATOR
Intervention: Traditional gated recurrent unit model
Number of subjects: 10
Study 35851368 — intervention group
Group type: EXPERIMENTAL
Intervention: Closure of the platysma muscle layer
Number of subjects: 92
Study 35851368 — intervention group
Group type: COMPARATOR
Intervention: Non-closure of the platysma muscle layer
Number of subjects: 92
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 plus cellular quadrivalent influenza vaccine
Number of subjects: 679
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 plus cellular quadrivalent influenza vaccine
Number of subjects: 679
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 plus MF59C adjuvanted, trivalent influenza vaccine
Number of subjects: 679
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 plus recombinant quadrivalent influenza vaccine
Number of subjects: 679
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 plus MF59C adjuvanted, trivalent influenza vaccine
Number of subjects: 679
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 plus recombinant quadrivalent influenza vaccine
Number of subjects: 679
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant administration of COVID-19 and influenza vaccines
Number of subjects: 679
Study 34774197 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant vaccination with ChAdOx1 or BNT162b2 plus an age-appropriate influenza vaccine
Number of subjects: 679
Study 33491390 — intervention group
Group type: EXPERIMENTAL
Intervention: BIA with the aid of DentalVibe
Number of subjects: 60
Study 33491390 — intervention group
Group type: COMPARATOR
Intervention: Traditional BIA
Number of subjects: 60
Study 35963295 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergame training
Number of subjects: 52
Study 35963295 — intervention group
Group type: COMPARATOR
Intervention: Motor-cognitive dual-task training
Number of subjects: 52
Study 33938672 — intervention group
Group type: EXPERIMENTAL
Intervention: CI-based hemodynamic management
Number of subjects: 60
Study 33938672 — intervention group
Group type: COMPARATOR
Intervention: MAP-based hemodynamic management
Number of subjects: 60
Study 32820000 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte-rich PRP (LR-PRP) injection
Number of subjects: 68
Study 32820000 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 68
Study 35704219 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma
Number of subjects: 55
Study 35704219 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluoride varnish (5%)
Number of subjects: 55
Study 35704219 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser (wavelength 2780 nm, frequency 20 Hz, power 0.25 W, energy density 44.3 J/cm2, pulse width of 150 µs for 30 s)
Number of subjects: 55
Study 35704219 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma + Er,Cr:YSGG laser
Number of subjects: 55
Study 35704219 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluoride varnish + Gluma
Number of subjects: 55
Study 34024809 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram combining radiomics signature and clinical features
Number of subjects: 300
Study 34024809 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 300
Study 34024809 — intervention group
Group type: COMPARATOR
Intervention: Radiomics signature model
Number of subjects: 300
Study 33135590 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness activity (body scan)
Number of subjects: 144
Study 33135590 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 144
Study 32089371 — intervention group
Group type: COMPARATOR
Intervention: High intensity interval training plus whole-body electromyostimulation (HIIT + EMS)
Number of subjects: 71
Study 32089371 — intervention group
Group type: COMPARATOR
Intervention: High intensity interval training (HIIT)
Number of subjects: 71
Study 32089371 — intervention group
Group type: COMPARATOR
Intervention: Concurrent training based on international physical activity recommendations (PAR group)
Number of subjects: 71
Study 32089371 — intervention group
Group type: EXPERIMENTAL
Intervention: No exercise (Control group)
Number of subjects: 71
Study 34621519 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin IV plus ascorbic acid (n=21)
Number of subjects: 41
Study 34621519 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin IV only (n=20)
Number of subjects: 41
Study 34621519 — intervention group
Group type: COMPARATOR
Intervention: Control group (vancomycin IV only)
Number of subjects: 41
Study 32158190 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimasartan 120 mg
Number of subjects: 365
Study 32158190 — intervention group
Group type: COMPARATOR
Intervention: Valsartan 160 mg
Number of subjects: 365
Study 35297659 — intervention group
Group type: EXPERIMENTAL
Intervention: LT3 treatment (0.8 μg/kg i.v. bolus followed by 0.113 μg/kg/h i.v. infusion for 48 hours)
Number of subjects: 37
Study 35297659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 35297659 — intervention group
Group type: EXPERIMENTAL
Intervention: LT3 treatment
Number of subjects: 37
Study 33544916 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational workshop on incontinence
Number of subjects: 392
Study 33796965 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound topical anesthetic (CTA) combined with photobiomodulation therapy (PBMT)
Number of subjects: 25
Study 33796965 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia with 2% lidocaine hydrochloride
Number of subjects: 25
Study 32729014 — intervention group
Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 0.5 mg/day
Number of subjects: 120
Study 32729014 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir Disoproxil Fumarate (TDF) 245 mg/day
Number of subjects: 120
Study 35504256 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 14
Study 35504256 — intervention group
Group type: COMPARATOR
Intervention: SiPAP
Number of subjects: 14
Study 32151227 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic nitrate drink (140-ml beetroot juice per day)
Number of subjects: 12
Study 32151227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34608614 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention developed to promote psychological and academic well-being
Number of subjects: 15
Study 34608614 — intervention group
Group type: COMPARATOR
Intervention: Business as usual (Control)
Number of subjects: 15
Study 34972894 — intervention group
Group type: EXPERIMENTAL
Intervention: Pythagorean Self‐Awareness Intervention (PSAI) for 8 weeks along with continuous positive airway pressure (CPAP) treatment
Number of subjects: 30
Study 34972894 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) treatment alone
Number of subjects: 30
Study 35700338 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTA-defined extent and stenosis severity of CAD based on the modified Duke Prognostic Index
Number of subjects: 2475
Study 34370911 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavored, non‐fluoridated, alcohol‐free mouthwash containing 0.1% chlorine dioxide
Number of subjects: 50
Study 34370911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 35743790 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy plus escitalopram
Number of subjects: 0
Study 35743790 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy plus placebo
Number of subjects: 0
Study 33319386 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Disease Self-Management Program (CDSMP) combined with interactive technology-enhanced coaching
Number of subjects: 90
Study 33319386 — intervention group
Group type: COMPARATOR
Intervention: Chronic Disease Self-Management Program (CDSMP) alone
Number of subjects: 90
Study 34146117 — intervention group
Group type: EXPERIMENTAL
Intervention: mono-J insertion for 6 hours after ureterorenoscopy
Number of subjects: 108
Study 34146117 — intervention group
Group type: COMPARATOR
Intervention: double-J insertion for 3-5 days after ureterorenoscopy
Number of subjects: 108
Study 35143453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic intervention (20-week program with three workshops)
Number of subjects: 190
Study 35143453 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 190
Study 32795144 — intervention group
Group type: EXPERIMENTAL
Intervention: Top commercially available diabetes apps
Number of subjects: 92
Study 35143219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive EMDR
Number of subjects: 96
Study 35143219 — intervention group
Group type: COMPARATOR
Intervention: Intensive PC
Number of subjects: 96
Study 33674871 — intervention group
Group type: EXPERIMENTAL
Intervention: IA (Ivermectin plus Albendazole)
Number of subjects: 144
Study 33674871 — intervention group
Group type: COMPARATOR
Intervention: ALB 400 mg
Number of subjects: 144
Study 33674871 — intervention group
Group type: COMPARATOR
Intervention: ALB 800 mg
Number of subjects: 144
Study 33674871 — intervention group
Group type: EXPERIMENTAL
Intervention: IA
Number of subjects: 144
Study 32133668 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visit by occupational therapist
Number of subjects: 65
Study 32133668 — intervention group
Group type: COMPARATOR
Intervention: Usual care (hospital-based assessment)
Number of subjects: 65
Study 34384941 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial flywheel resistance training (N = 21)
Number of subjects: 42
Study 34384941 — intervention group
Group type: COMPARATOR
Intervention: Heavy slow resistance training (N = 21)
Number of subjects: 42
Study 33065663 — intervention group
Group type: EXPERIMENTAL
Intervention: Taylor Spatial Frame (TSF)
Number of subjects: 63
Study 33065663 — intervention group
Group type: COMPARATOR
Intervention: Reamed Intramedullary Nail (IMN)
Number of subjects: 63
Study 35620986 — intervention group
Group type: COMPARATOR
Intervention: Saline hydration alone (n=81)
Number of subjects: 241
Study 35620986 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bicarbonate (n=78)
Number of subjects: 241
Study 35620986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bicarbonate (n=82)
Number of subjects: 241
Study 35620986 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients achieving a pH >6 before angiography (n=145)
Number of subjects: 241
Study 34033648 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 6 mg QD for 7 to 10 days
Number of subjects: 216
Study 34033648 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone 250 to 500 mg daily for 3 days followed by oral prednisone 50 mg daily for 14 days
Number of subjects: 216
Study 32517490 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin training (24 weeks, 3 days a week, 40 minutes per session)
Number of subjects: 48
Study 34097649 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Technique (EFT)
Number of subjects: 162
Study 34097649 — intervention group
Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 162
Study 34097649 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 162
Study 33652088 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation (cTBS) over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 49
Study 33652088 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation (cTBS) over the right hemisphere
Number of subjects: 49
Study 33652088 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 49
Study 32780705 — intervention group
Group type: EXPERIMENTAL
Intervention: DCOT-LS-SVMs
Number of subjects: 0
Study 32780705 — intervention group
Group type: EXPERIMENTAL
Intervention: IDCOT-LS-SVMs
Number of subjects: 0
Study 32331053 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone monotherapy
Number of subjects: 1192
Study 32331053 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone adjunctive therapy
Number of subjects: 1192
Study 32331053 — intervention group
Group type: COMPARATOR
Intervention: Placebo (short-term)
Number of subjects: 1192
Study 32331053 — intervention group
Group type: COMPARATOR
Intervention: Placebo (adjunctive therapy)
Number of subjects: 1192
Study 32331053 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive lurasidone (recurrence prevention study)
Number of subjects: 1192
Study 32331053 — intervention group
Group type: COMPARATOR
Intervention: Adjunctive placebo (recurrence prevention study)
Number of subjects: 1192
Study 34048941 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labour (IOL)
Number of subjects: 38
Study 35685535 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame Oil (SO), 30 grams per day for 12 weeks
Number of subjects: 60
Study 35685535 — intervention group
Group type: COMPARATOR
Intervention: Sunflower Oil (SFO), 30 grams per day for 12 weeks
Number of subjects: 60
Study 34168425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold intraoperative irrigating solution (2.7±0.1°C)
Number of subjects: 100